Individual Differences in Drug Response

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions
Differential Female Response to Δ9-tetrahydrocannabinol (THC)
Interventions
DRUG

Dronabinol

THC (Marinol® \[dronabinol\]; Solvay Pharmaceuticals) will be orally administered in doses of 7.5 mg and 15 mg, in opaque capsules with dextrose filler. Placebo capsules contain only dextrose. These doses of THC are known to produce performance impairments as well as subjective intoxication with little to no adverse reactions in experienced occasional, but non-daily cannabis users (Ménétrey et al., 2005; Issa et al. 2016).

DRUG

dextrose

We are administering dextrose to health volunteers for our placebo group

Trial Locations (1)

60615

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT03809546 - Individual Differences in Drug Response | Biotech Hunter | Biotech Hunter